Double blind, multicentre, randomized, placebo-controlled trial to evaluate safety and efficacy of pitolisant in children from 6 to less than 18 years with narcolepsy with/without cataplexy, followed by a prolonged open-label period
CompletedCTIS2024-515568-30-00
Bioprojet PharmaNarcolepsy
End: 2025-06-05Target: 57Updated: 2025-06-03